Energetic stress: The reciprocal relationship between energy availability and the stress response

Physiology and Behavior

Volumn 166, Issue , 2016, Pages 43-55

  Harrell, C S ^a   Gillespie, C F ^b   Neigh, G N ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glucocorticoid; HPA axis; Metabolic dysfunction; Obesity; Stress

Indexed keywords

GLUCOCORTICOID; NEUROPEPTIDE;

ADRENERGIC SYSTEM; CORRELATION ANALYSIS; DIABETES MELLITUS; DIET THERAPY; ENERGY METABOLISM; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; MENTAL DISEASE; METABOLIC DISORDER; METABOLISM; MOLECULAR BIOLOGY; NEUROENDOCRINE SYSTEM; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRESS; ANIMAL; COMPLICATION; MENTAL STRESS; NEUROSECRETION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ENERGY METABOLISM; GLUCOCORTICOIDS; HUMANS; METABOLIC DISEASES; NEUROSECRETORY SYSTEMS; STRESS, PSYCHOLOGICAL;

EID: 84951760509     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2015.10.009     Document Type: Review

References (214)

1. [1] Abe, N., Uchida, S., Otsuki, K., Hobara, T., Yamagata, H., Higuchi, F., Shibata, T., Watanabe, Y., Altered sirtuin deacetylase gene expression in patients with a mood disorder. J. Psychiatr. Res. 45 (2011), 1106–1112.
2. [2] Adam, T.C., Epel, E.S., Stress, eating and the reward system. Physiol. Behav. 91 (2007), 449–458.
3. [3] Alberti, K.G., Zimmet, P., Shaw, J., Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet. Med. 23 (2006), 469–480.
4. [4] Amat, R., Solanes, G., Giralt, M., Villarroya, F., SIRT1 is involved in glucocorticoid-mediated control of uncoupling protein-3 gene transcription. J. Biol. Chem. 282 (2007), 34066–34076.
5. [5] Anderson, J.L., Edney, R.J., Whelan, K., Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment. Pharmacol. Ther. 36 (2012), 503–516.
6. [6] Anderson, R.J., Freedland, K.E., Clouse, R.E., Lustman, P.J., The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24 (2001), 1069–1078.
7. [7] Arase, K., Shargill, N.S., Bray, G.A., Effects of corticotropin releasing factor on genetically obese (fatty) rats. Physiol. Behav. 45 (1989), 565–570.
8. [8] Arkan, M.C., Hevener, A.L., Greten, F.R., Maeda, S., Li, Z.W., Long, J.M., Wynshaw-Boris, A., Poli, G., Olefsky, J., Karin, M., IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11 (2005), 191–198.
9. [9] Bailey, M.T., Dowd, S.E., Galley, J.D., Hufnagle, A.R., Allen, R.G., Lyte, M., Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav. Immun. 25 (2011), 397–407.
10. [10] Bale, T.L., Vale, W.W., CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 44 (2004), 525–557.
11. [11] Balsevich, G., Uribe, A., Wagner, K.V., Hartmann, J., Santarelli, S., Labermaier, C., Schmidt, M.V., Interplay between diet-induced obesity and chronic stress in mice: potential role of FKBP51. J. Endocrinol. 222 (2014), 15–26.
12. [12] Becker, J.B., Hu, M., Sex differences in drug abuse. Front. Neuroendocrinol. 29 (2008), 36–47.
13. [13] Bell, M.E., Bhatnagar, S., Liang, J., Soriano, L., Nagy, T.R., Dallman, M.F., Voluntary sucrose ingestion, like corticosterone replacement, prevents the metabolic deficits of adrenalectomy. J. Neuroendocrinol. 12 (2000), 461–470.
14. [14] Bernard, C., An Introduction to the Study of Medicine. 1980, Classics of Medicine Library, Birmingham, AL.
15. [15] Bjorntorp, P., Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 13 (1997), 795–803.
16. [16] Bjorntorp, P., Rosmond, R., Hypothalamic origin of the metabolic syndrome X. Ann. N. Y. Acad. Sci. 892 (1999), 297–307.
17. [17] Bjorntorp, P., Rosmond, R., The metabolic syndrome—a neuroendocrine disorder?. J. Nutr. 83:Suppl. 1 (2000), S49–S57.
18. [18] Blaine, B., Does depression cause obesity?: a meta-analysis of longitudinal studies of depression and weight control. J. Health Psychol. 13 (2008), 1190–1197.
19. [19] Bland, M.L., Birnbaum, M.J., Cell biology. Adapting to energetic stress. Science 332 (2011), 1387–1388.
20. [20] Borg, W.P., During, M.J., Sherwin, R.S., Borg, M.A., Brines, M.L., Shulman, G.I., Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J. Clin. Invest. 93 (1994), 1677–1682.
21. [21] Bourke, C.H., Harrell, C.S., Neigh, G.N., Stress-induced sex differences: adaptations mediated by the glucocorticoid receptor. Horm. Behav. 62 (2012), 210–218.
22. [22] Bourke, C.H., Neigh, G.N., Behavioral effects of chronic adolescent stress are sustained and sexually dimorphic. Horm. Behav. 60 (2011), 112–120.
23. [23] Bourke, C.H., Raees, M.Q., Malviya, S., Bradburn, C.A., Binder, E.B., Neigh, G.N., Glucocorticoid sensitizers Bag1 and ppid are regulated by adolescent stress in a sex-dependent manner. Psychoneuroendocrinology 38 (2013), 84–93.
24. [24] Bravo, J.A., Forsythe, P., Chew, M.V., Escaravage, E., Savignac, H.M., Dinan, T.G., Bienenstock, J., Cryan, J.F., Ingestion of lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 16050–16055.
25. [25] Brindley, D.N., Cooling, J., Glenny, H.P., Burditt, S.L., McKechnie, I.S., Effects of chronic modification of dietary fat and carbohydrate on the insulin, corticosterone and metabolic responses of rats fed acutely with glucose, fructose or ethanol. Biochem. J. 200 (1981), 275–283.
26. [26] Brindley, D.N., Saxton, J., Shahidullah, H., Armstrong, M., Possible relationships between changes in body weight set-point and stress metabolism after treating rats chronically with D-fenfluramine. Effects of feeding rats acutely with fructose on the metabolism of corticosterone, glucose, fatty acids, glycerol and triacylglycerol. Biochem. Pharmacol. 34 (1985), 1265–1271.
27. [27] Briscoe, V.J., Griffith, M.L., Davis, S.N., The role of glimepiride in the treatment of type 2 diabetes mellitus. Expert Opin. Drug Metab. Toxicol. 6 (2010), 225–235.
28. [28] Brunner, E.J., Hemingway, H., Walker, B.R., Page, M., Clarke, P., Juneja, M., Shipley, M.J., Kumari, M., Andrew, R., Seckl, J.R., Papadopoulos, A., Checkley, S., Rumley, A., Lowe, G.D., Stansfeld, S.A., Marmot, M.G., Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case–control study. Circulation 106 (2002), 2659–2665.
29. [29] Burke, H.M., Davis, M.C., Otte, C., Mohr, D.C., Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology 30 (2005), 846–856.
30. [30] Buwalda, B., de Boer, S.F., Van Kalkeren, A.A., Koolhaas, J.M., Physiological and behavioral effects of chronic intracerebroventricular infusion of corticotropin-releasing factor in the rat. Psychoneuroendocrinology 22 (1997), 297–309.
31. [31] Cannon, W.B., The James–Lange theory of emtions: a critical examination and an alternative theory. Am. J. Psychol. 39 (1927), 106–124.
32. [32] Carney, R.M., Saunders, R.D., Freedland, K.E., Stein, P., Rich, M.W., Jaffe, A.S., Association of depression with reduced heart rate variability in coronary artery disease. Am. J. Cardiol. 76 (1995), 562–564.
33. [33] Carroll, T., Aron, D., Findling, J., Tyrrell, B., Glucocorticoids and adrenal androgens. Gardner, D., Shoback, D., (eds.) Greenspan's Basic & Clinical Endocrinology, 2011, McGraw-Hill, New York, NY.
34. [34] Charmandari, E., Tsigos, C., Chrousos, G., Endocrinology of the stress response. Annu. Rev. Physiol. 67 (2005), 259–284.
35. [35] Chiba, S., Numakawa, T., Ninomiya, M., Richards, M.C., Wakabayashi, C., Kunugi, H., Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 39 (2012), 112–119.
36. [36] Chrousos, G.P., Gold, P.W., The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267 (1992), 1244–1252.
37. [37] Cnop, M., Havel, P.J., Utzschneider, K.M., Carr, D.B., Sinha, M.K., Boyko, E.J., Retzlaff, B.M., Knopp, R.H., Brunzell, J.D., Kahn, S.E., Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46 (2003), 459–469.
38. [38] Cole, M.A., Kim, P.J., Kalman, B.A., Spencer, R.L., Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies. Psychoneuroendocrinology 25 (2000), 151–167.
39. [39] Correia, M.L., Haynes, W.G., Rahmouni, K., Morgan, D.A., Sivitz, W.I., Mark, A.L., The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 51 (2002), 439–442.
40. [40] Cryan, J.F., Dinan, T.G., Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 13 (2012), 701–712.
41. [41] Cryer, E., Davis, S.N., Chapter 345: Hypoglycemia. Longo, D.L., Fauci, A.S., Kasper, D.L., Hauser, S.L., Jameson, J., Loscalzo, J., (eds.) Harrison's Principles of Internal Medicine, 18e, 2012, McGraw-Hill, New York, NY.
42. [42] Cullen, M.J., Ling, N., Foster, A.C., Pelleymounter, M.A., Urocortin, corticotropin releasing factor-2 receptors and energy balance. Endocrinology 142 (2001), 992–999.
43. [43] da Silva, A.A., do Carmo, J.M., Hall, J.E., Role of leptin and central nervous system melanocortins in obesity hypertension. Curr. Opin. Nephrol. Hypertens. 22 (2013), 135–140.
44. [44] Dallman, M.F., Akana, S.F., Bhatnagar, S., Bell, M.E., Choi, S., Chu, A., Horsley, C., Levin, N., Meijer, O., Soriano, L.R., Strack, A.M., Viau, V., Starvation: early signals, sensors, and sequelae. Endocrinology 140 (1999), 4015–4023.
45. [45] Dallman, M.F., Pecoraro, N., Akana, S.F., La Fleur, S.E., Gomez, F., Houshyar, H., Bell, M.E., Bhatnagar, S., Laugero, K.D., Manalo, S., Chronic stress and obesity: a new view of “comfort food”. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 11696–11701.
46. [46] Dallman, M.F., Pecoraro, N.C., la Fleur, S.E., Chronic stress and comfort foods: self-medication and abdominal obesity. Brain Behav. Immun. 19 (2005), 275–280.
47. [47] Dedic, N., Touma, C., Romanowski, C.P., Schieven, M., Kuhne, C., Ableitner, M., Lu, A., Holsboer, F., Wurst, W., Kimura, M., Deussing, J.M., Assessing behavioural effects of chronic HPA axis activation using conditional CRH-overexpressing mice. Cell. Mol. Neurobiol. 32 (2012), 815–828.
48. [48] Diane, A., Pierce, W.D., Mangat, R., Borthwick, F., Nelson, R., Russell, J.C., Heth, C.D., Jacobs, R.L., Vine, D.F., Proctor, S.D., Differential expression of hypothalamic, metabolic and inflammatory genes in response to short-term calorie restriction in juvenile obese- and lean-prone JCR rats. Nutr. Diabetes, 5, 2015, e178.
49. [49] Diaz Heijtz, R., Wang, S., Anuar, F., Qian, Y., Bjorkholm, B., Samuelsson, A., Hibberd, M.L., Forssberg, H., Pettersson, S., Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 3047–3052.
50. [50] Dinan, T.G., Cryan, J.F., Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology. Psychoneuroendocrinology 37 (2012), 1369–1378.
51. [51] Dinan, T.G., Stanton, C., Cryan, J.F., Psychobiotics: a novel class of psychotropic. Biol. Psychiatry 74 (2013), 720–726.
52. [52] Dobrian, A.D., Davies, M.J., Prewitt, R.L., Lauterio, T.J., Development of hypertension in a rat model of diet-induced obesity. Hypertension 35 (2000), 1009–1015.
53. [53] Dockray, S., Susman, E.J., Dorn, L.D., Depression, cortisol reactivity, and obesity in childhood and adolescence. J. Adolesc. Health 45 (2009), 344–350.
54. [54] Dotson, S., Freeman, R., Failing, H.J., Adler, G.K., Hypoglycemia increases serum interleukin-6 levels in healthy men and women. Diabetes Care 31 (2008), 1222–1223.
55. [55] Douyon, L., Schteingart, D.E., Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. Endocrinol. Metab. Clin. N. Am. 31 (2002), 173–189.
56. [56] Duclos, M., Gatta, B., Corcuff, J.B., Rashedi, M., Pehourcq, F., Roger, P., Fat distribution in obese women is associated with subtle alterations of the hypothalamic-pituitary-adrenal axis activity and sensitivity to glucocorticoids. Clin. Endocrinol. 55 (2001), 447–454.
57. [57] Dunbar, J.C., Hu, Y., Lu, H., Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 46 (1997), 2040–2043.
58. [58] Duong, M., Cohen, J.I., Convit, A., High cortisol levels are associated with low quality food choice in type 2 diabetes. Endocrine 41 (2012), 76–81.
59. [59] Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R., Nelson, K.E., Relman, D.A., Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638.
60. [60] Edwards, A.V., Jones, C.T., The effect of splanchnic nerve stimulation on adrenocortical activity in conscious calves. J. Physiol. 382 (1987), 385–396.
61. [61] Edwards, A.V., Jones, C.T., Autonomic control of adrenal function. J. Anat. 183:Pt 2 (1993), 291–307.
62. [62] Engeland, W.C., Arnhold, M.M., Neural circuitry in the regulation of adrenal corticosterone rhythmicity. Endocrine 28 (2005), 325–332.
63. [63] Erturk, E., Jaffe, C.A., Barkan, A.L., Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test. J. Clin. Endocrinol. Metab. 83 (1998), 2350–2354.
64. [64] Esler, M., Rumantir, M., Wiesner, G., Kaye, D., Hastings, J., Lambert, G., Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am. J. Hypertens. 14 (2001), 304S–309S.
65. [65] Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., Giugliano, D., Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106 (2002), 2067–2072.
66. [66] Fan, W., Boston, B.A., Kesterson, R.A., Hruby, V.J., Cone, R.D., Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385 (1997), 165–168.
67. [67] Farooqi, I.S., Yeo, G.S., Keogh, J.M., Aminian, S., Jebb, S.A., Butler, G., Cheetham, T., O'Rahilly, S., Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J. Clin. Invest. 106 (2000), 271–279.
68. [68] Fava, M., Diagnosis and definition of treatment-resistant depression. Biol. Psychiatry 53 (2003), 649–659.
69. [69] Fekete, E.M., Zhao, Y., Szucs, A., Sabino, V., Cottone, P., Rivier, J., Vale, W.W., Koob, G.F., Zorrilla, E.P., Systemic urocortin 2, but not urocortin 1 or stressin1-a, suppresses feeding via CRF2 receptors without malaise and stress. Br. J. Pharmacol. 164 (2011), 1959–1975.
70. [70] Foster, J.A., McVey Neufeld, K.A., Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 36 (2013), 305–312.
71. [71] Foster, M.T., Warne, J.P., Ginsberg, A.B., Horneman, H.F., Pecoraro, N.C., Akana, S.F., Dallman, M.F., Palatable foods, stress, and energy stores sculpt corticotropin-releasing factor, adrenocorticotropin, and corticosterone concentrations after restraint. Endocrinology 150 (2009), 2325–2333.
72. [72] Fountoulakis, K.N., Iacovides, A., Grammaticos, P., St Kaprinis, G., Bech, P., Thyroid function in clinical subtypes of major depression: an exploratory study. BMC Psychiatry, 4, 2004, 6.
73. [73] Freeman, M.P., Rapaport, M.H., Omega-3 fatty acids and depression: from cellular mechanisms to clinical care. J. Clin. Psychiatry 72 (2011), 258–259.
74. [74] Fu, L.Y., Acuna-Goycolea, C., van den Pol, A.N., Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J. Neurosci. 24 (2004), 8741–8751.
75. [75] Garrison, R.J., Kannel, W.B., Stokes, J. 3rd, Castelli, W.P., Incidence and precursors of hypertension in young adults: the Framingham offspring study. Prev. Med. 16 (1987), 235–251.
76. [76] George, S.A., Khan, S., Briggs, H., Abelson, J.L., CRH-stimulated cortisol release and food intake in healthy, non-obese adults. Psychoneuroendocrinology 35 (2010), 607–612.
77. [77] Gill, S.R., Pop, M., Deboy, R.T., Eckburg, P.B., Turnbaugh, P.J., Samuel, B.S., Gordon, J.I., Relman, D.A., Fraser-Liggett, C.M., Nelson, K.E., Metagenomic analysis of the human distal gut microbiome. Science 312 (2006), 1355–1359.
78. [78] Gogitidze Joy, N., Hedrington, M.S., Briscoe, V.J., Tate, D.B., Ertl, A.C., Davis, S.N., Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals. Diabetes Care 33 (2010), 1529–1535.
79. [79] Guo, S.S., Wu, W., Chumlea, W.C., Roche, A.F., Predicting overweight and obesity in adulthood from body mass index values in childhood and adolescence. J. Clin. Nutr. 76 (2002), 653–658.
80. [80] Haigis, M.C., Guarente, L.P., Mammalian sirtuins–emerging roles in physiology, aging, and calorie restriction. Genes Dev. 20 (2006), 2913–2921.
81. [81] Heilbronn, L.K., Ravussin, E., Calorie restriction and aging: review of the literature and implications for studies in humans. Am. J. Clin. Nutr. 78 (2003), 361–369.
82. [82] Heilig, M., McLeod, S., Brot, M., Heinrichs, S.C., Menzaghi, F., Koob, G.F., Britton, K.T., Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8 (1993), 357–363.
83. [83] Heilig, M., Wahlestedt, C., Ekman, R., Widerlov, E., Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain. Eur. J. Pharmacol. 147 (1988), 465–467.
84. [84] Heilig, M., Zachrisson, O., Thorsell, A., Ehnvall, A., Mottagui-Tabar, S., Sjogren, M., Asberg, M., Ekman, R., Wahlestedt, C., Agren, H., Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. J. Psychiatr. Res. 38 (2004), 113–121.
85. [85] Herder, C., Schneitler, S., Rathmann, W., Haastert, B., Schneitler, H., Winkler, H., Bredahl, R., Hahnloser, E., Martin, S., Low-grade inflammation, obesity, and insulin resistance in adolescents. J. Clin. Endocrinol. Metab. 92 (2007), 4569–4574.
86. [86] Herman, J.P., Cullinan, W.E., Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 20 (1997), 78–84.
87. [87] Hildebrandt, M.A., Hoffmann, C., Sherrill-Mix, S.A., Keilbaugh, S.A., Hamady, M., Chen, Y.Y., Knight, R., Ahima, R.S., Bushman, F., Wu, G.D., High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137 (2009), 1716–1724, e1711-1712.
88. [88] Hotamisligil, G.S., Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. Diabetes 54:Suppl 2 (2005), S73–S78.
89. [89] Hotamisligil, G.S., Shargill, N.S., Spiegelman, B.M., Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993), 87–91.
90. [90] Hotta, M., Shibasaki, T., Yamauchi, N., Ohno, H., Benoit, R., Ling, N., Demura, H., The effects of chronic central administration of corticotropin-releasing factor on food intake, body weight, and hypothalamic-pituitary-adrenocortical hormones. Life Sci. 48 (1991), 1483–1491.
91. [91] Huszar, D., Lynch, C.A., Fairchild-Huntress, V., Dunmore, J.H., Fang, Q., Berkemeier, L.R., Gu, W., Kesterson, R.A., Boston, B.A., Cone, R.D., Smith, F.J., Campfield, L.A., Burn, P., Lee, F., Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88 (1997), 131–141.
92. [92] IDF (2006) The IDF worldwide consensus definition of metabolic syndrome. (Alberti, G. et al., eds), p 24 (Brussels, Belgium).
93. [93] Inui, A., Transgenic approach to the study of body weight regulation. Pharmacol. Rev. 52 (2000), 35–61.
94. [94] Jacob, H.J., Lindpaintner, K., Lincoln, S.E., Kusumi, K., Bunker, R.K., Mao, Y.P., Ganten, D., Dzau, V.J., Lander, E.S., Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell 67 (1991), 213–224.
95. [95] Jessop, D.S., Dallman, M.F., Fleming, D., Lightman, S.L., Resistance to glucocorticoid feedback in obesity. J. Clin. Endocrinol. Metab. 86 (2001), 4109–4114.
96. [96] Joffe, R.T., Marriott, M., Thyroid hormone levels and recurrence of major depression. Am. J. Psychiatry 157 (2000), 1689–1691.
97. [97] Joyner, J.M., Hutley, L.J., Cameron, D.P., Glucocorticoid receptors in human preadipocytes: regional and gender differences. J. Endocrinol. 166 (2000), 145–152.
98. [98] Kalantar-Zadeh, K., Kopple, J.D., Humphreys, M.H., Block, G., Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol. Dial. Transplant. 19 (2004), 1507–1519.
99. [99] Karason, K., Molgaard, H., Wikstrand, J., Sjostrom, L., Heart rate variability in obesity and the effect of weight loss. Am. J. Cardiol. 83 (1999), 1242–1247.
100. [100] Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R., Rush, A.J., Walters, E.E., Wang, P.S., National Comorbidity Survey R, The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R). JAMA 289 (2003), 3095–3105.
101. [101] Kitada, M., Koya, D., SIRT1 in type 2 diabetes: mechanisms and therapeutic potential. Diabetes Metab. J. 37 (2013), 315–325.
102. [102] Koenig, J.E., Spor, A., Scalfone, N., Fricker, A.D., Stombaugh, J., Knight, R., Angenent, L.T., Ley, R.E., Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. U. S. A. 108:Suppl 1 (2011), 4578–4585.
103. [103] Koob, G.F., The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res. 1314 (2010), 3–14.
104. [104] Kotelevtsev, Y., Holmes, M.C., Burchell, A., Houston, P.M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C.R., Seckl, J.R., Mullins, J.J., 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 14924–14929.
105. [105] Krishna, R., Gumbiner, B., Stevens, C., Musser, B., Mallick, M., Suryawanshi, S., Maganti, L., Zhu, H., Han, T.H., Scherer, L., Simpson, B., Cosgrove, D., Gottesdiener, K., Amatruda, J., Rolls, B.J., Blundell, J., Bray, G.A., Fujioka, K., Heymsfield, S.B., Wagner, J.A., Herman, G.A., Potent and selective agonism of the melanocortin receptor 4 with MK-0493 does not induce weight loss in obese human subjects: energy intake predicts lack of weight loss efficacy. Clin. Pharmacol. Ther. 86 (2009), 659–666.
106. [106] Kurtz, T.W., Morris, R.C., Pershadsingh, H.A., The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension 13 (1989), 896–901.
107. [107] Lamers, F., Vogelzangs, N., Merikangas, K.R., de Jonge, P., Beekman, A.T., Penninx, B.W., Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol. Psychiatry 18 (2013), 692–699.
108. [108] Landsberg, L., Diet, obesity and hypertension: a hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q. J. Med. 61 (1986), 1081–1090.
109. [109] Lange, C.G., James, W., The Emotions. 1922 (Baltimore, MD).
110. [110] Levin, B.E., Arcuate NPY neurons and energy homeostasis in diet-induced obese and resistant rats. Am. J. Physiol. 276 (1999), R382–R387.
111. [111] Ley, R.E., Backhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 11070–11075.
112. [112] Lin, S., Storlien, L.H., Huang, X.F., Leptin receptor, NPY, POMC mRNA expression in the diet-induced obese mouse brain. Brain Res. 875 (2000), 89–95.
113. [113] Linkowski, P., Kerkhofs, M., Van Onderbergen, A., Hubain, P., Copinschi, G., L'Hermite-Baleriaux, M., Leclercq, R., Brasseur, M., Mendlewicz, J., Van Cauter, E., The 24-hour profiles of cortisol, prolactin, and growth hormone secretion in mania. Arch. Gen. Psychiatry 51 (1994), 616–624.
114. [114] Ljung, T., Andersson, B., Bengtsson, B.A., Bjorntorp, P., Marin, P., Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose–response study. Obes. Res. 4 (1996), 277–282.
115. [115] Lovejoy, J.C., Sainsbury, A., Stock Conference Working, G., Sex differences in obesity and the regulation of energy homeostasis. Obes. Rev. 10 (2009), 154–167.
116. [116] Mark, A.L., Selective leptin resistance revisited. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305 (2013), R566–R581.
117. [117] Martinez, V., Wang, L., Rivier, J.E., Vale, W., Tache, Y., Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. J. Pharmacol. Exp. Ther. 301 (2002), 611–617.
118. [118] Masuzaki, H., Paterson, J., Shinyama, H., Morton, N.M., Mullins, J.J., Seckl, J.R., Flier, J.S., A transgenic model of visceral obesity and the metabolic syndrome. Science 294 (2001), 2166–2170.
119. [119] Maury, E., Brichard, S.M., Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol. Cell. Endocrinol. 314 (2010), 1–16.
120. [120] Maury, E., Ehala-Aleksejev, K., Guiot, Y., Detry, R., Vandenhooft, A., Brichard, S.M., Adipokines oversecreted by omental adipose tissue in human obesity. Am. J. Physiol. Endocrinol. Metab. 293 (2007), E656–E665.
121. [121] Mayer, E.A., Gut feelings: the emerging biology of gut-brain communication. Nat. Rev. Neurosci. 12 (2011), 453–466.
122. [122] Mayer, E.A., Naliboff, B.D., Chang, L., Coutinho, S.V., V. Stress and irritable bowel syndrome. Am. J. Physiol. Gastrointest. Liver Physiol. 280 (2001), G519–G524.
123. [123] McCarty, M.F., Modulation of adipocyte lipoprotein lipase expression as a strategy for preventing or treating visceral obesity. Med. Hypotheses 57 (2001), 192–200.
124. [124] McCormick, C.M., Green, M.R., Cameron, N.M., Nixon, F., Levy, M.J., Clark, R.A., Deficits in male sexual behavior in adulthood after social instability stress in adolescence in rats. Horm. Behav. 63 (2013), 5–12.
125. [125] McEwen, B.S., Stress, adaptation, and disease. Allostasis and allostatic load. Ann. Acad. Sci. 840 (1998), 33–44.
126. [126] McEwen, B.S., Stress and hippocampal plasticity. Annu. Rev. Neurosci. 22 (1999), 105–122.
127. [127] Meewisse, M.L., Reitsma, J.B., de Vries, G.J., Gersons, B.P., Olff, M., Cortisol and post-traumatic stress disorder in adults: systematic review and meta-analysis. Br. J. Psychiatry 191 (2007), 387–392.
128. [128] Michopoulos, V., Toufexis, D., Wilson, M.E., Social stress interacts with diet history to promote emotional feeding in females. Psychoneuroendocrinology 37 (2012), 1479–1490.
129. [129] Miller, B.F., Hamilton, K.L., A perspective on the determination of mitochondrial biogenesis. Am. J. Physiol. Endocrinol. Metab. 302 (2012), E496–E499.
130. [130] Moore, C.J., Johnson, Z.P., Higgins, M., Toufexis, D., Wilson, M.E., Antagonism of corticotrophin-releasing factor type 1 receptors attenuates caloric intake of free feeding subordinate female rhesus monkeys in a rich dietary environment. J. Neuroendocrinol. 27 (2015), 33–43.
131. [131] Morley, J.E., Levine, A.S., Gosnell, B.A., Kneip, J., Grace, M., Effect of neuropeptide Y on ingestive behaviors in the rat. Am. J. Physiol. 252 (1987), R599–R609.
132. [132] Mountjoy, K.G., Robbins, L.S., Mortrud, M.T., Cone, R.D., The cloning of a family of genes that encode the melanocortin receptors. Science 257 (1992), 1248–1251.
133. [133] Muramatsu, Y., Fukushima, K., Iino, K., Totsune, K., Takahashi, K., Suzuki, T., Hirasawa, G., Takeyama, J., Ito, M., Nose, M., Tashiro, A., Hongo, M., Oki, Y., Nagura, H., Sasano, H., Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa. Peptides 21 (2000), 1799–1809.
134. [134] Musselman, D.L., Nemeroff, C.B., Depression and endocrine disorders: focus on the thyroid and adrenal system. Br. J. Psychiatry Suppl., 123-128, 1996.
135. [135] Nadeau, K., Dabelea, D., Epidemiology of type 2 diabetes in children and adolescents. Endocr. Res. 33 (2008), 35–58.
136. [136] Nakai, Y., Hamagaki, S., Takagi, R., Taniguchi, A., Kurimoto, F., Plasma concentrations of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 84 (1999), 1226–1228.
137. [137] Nakayama, S., Nishiyama, M., Iwasaki, Y., Shinahara, M., Okada, Y., Tsuda, M., Okazaki, M., Tsugita, M., Taguchi, T., Makino, S., Stenzel-Poore, M.P., Hashimoto, K., Terada, Y., Corticotropin-releasing hormone (CRH) transgenic mice display hyperphagia with increased agouti-related protein mRNA in the hypothalamic arcuate nucleus. Endocr. J. 58 (2011), 279–286.
138. [138] Nasrallah, H., A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology 28:Suppl 1 (2003), 83–96.
139. [139] Ogden, C.L., Carroll, M.D., Curtin, L.R., Lamb, M.M., Flegal, K.M., Prevalence of high body mass index in US children and adolescents, 2007–2008. JAMA 303 (2010), 242–249.
140. [140] Ogden, C.L., Carroll, M.D., Kit, B.K., Flegal, K.M., Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 311 (2014), 806–814.
141. [141] Pace, T.W., Miller, A.H., Cytokines and glucocorticoid receptor signaling. Relevance to major depression. Ann. Acad. Sci. 1179 (2009), 86–105.
142. [142] Panagiotakopoulos, L., Neigh, G.N., Development of the HPA axis: where and when do sex differences manifest?. Front. Neuroendocrinol. 35 (2014), 285–302.
143. [143] Pankevich, D.E., Mueller, B.R., Brockel, B., Bale, T.L., Prenatal stress programming of offspring feeding behavior and energy balance begins early in pregnancy. Physiol. Behav. 98 (2009), 94–102.
144. [144] Papakostas, G.I., Shelton, R.C., Zajecka, J.M., Etemad, B., Rickels, K., Clain, A., Baer, L., Dalton, E.D., Sacco, G.R., Schoenfeld, D., Pencina, M., Meisner, A., Bottiglieri, T., Nelson, E., Mischoulon, D., Alpert, J.E., Barbee, J.G., Zisook, S., Fava, M., L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am. J. Psychiatry 169 (2012), 1267–1274.
145. [145] Pariante, C.M., Lightman, S.L., The HPA axis in major depression: classical theories and new developments. Trends Neurosci. 31 (2008), 464–468.
146. [146] Parylak, S.L., Koob, G.F., Zorrilla, E.P., The dark side of food addiction. Physiol. Behav. 104 (2011), 149–156.
147. [147] Pasquali, R., Anconetani, B., Chattat, R., Biscotti, M., Spinucci, G., Casimirri, F., Vicennati, V., Carcello, A., Labate, A.M., Hypothalamic–pituitary–adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress. Metab. Clin. Exp. 45 (1996), 351–356.
148. [148] Pasquali, R., Biscotti, D., Spinucci, G., Vicennati, V., Genazzani, A.D., Sgarbi, L., Casimirri, F., Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution. Clin. Endocrinol. 48 (1998), 603–612.
149. [149] Pasquali, R., Vicennati, V., Cacciari, M., Pagotto, U., The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann. N. Y. Acad. Sci. 1083 (2006), 111–128.
150. [150] Pecoraro, N., Reyes, F., Gomez, F., Bhargava, A., Dallman, M.F., Chronic stress promotes palatable feeding, which reduces signs of stress: feedforward and feedback effects of chronic stress. Endocrinology 145 (2004), 3754–3762.
151. [151] Pedersen, S.B., Jonler, M., Richelsen, B., Characterization of regional and gender differences in glucocorticoid receptors and lipoprotein lipase activity in human adipose tissue. J. Clin. Endocrinol. Metab. 78 (1994), 1354–1359.
152. [152] Posserud, I., Agerforz, P., Ekman, R., Bjornsson, E.S., Abrahamsson, H., Simren, M., Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut 53 (2004), 1102–1108.
153. [153] Psaltopoulou, T., Sergentanis, T.N., Panagiotakos, D.B., Sergentanis, I.N., Kosti, R., Scarmeas, N., Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis. Ann. Neurol. 74 (2013), 580–591.
154. [154] Rahmouni, K., Morgan, D.A., Morgan, G.M., Mark, A.L., Haynes, W.G., Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 54 (2005), 2012–2018.
155. [155] Ramirez, M.E., McMurry, M.P., Wiebke, G.A., Felten, K.J., Ren, K., Meikle, A.W., Iverius, P.H., Evidence for sex steroid inhibition of lipoprotein lipase in men: comparison of abdominal and femoral adipose tissue. Metab. Clin. Exp. 46 (1997), 179–185.
156. [156] Rapaport, M.H., Nierenberg, A.A., Schettler, P.J., Kinkead, B., Cardoos, A., Walker, R., Mischoulon, D., Inflammation as a Predictive Biomarker for Response to Omega-3 Fatty Acids in Major Depressive Disorder: A Proof-of-Concept Study. 2015, Molecular Psychiatry.
157. [157] Rask, E., Walker, B.R., Soderberg, S., Livingstone, D.E., Eliasson, M., Johnson, O., Andrew, R., Olsson, T., Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J. Clin. Endocrinol. Metab. 87 (2002), 3330–3336.
158. [158] Reagan, L.P., Diabetes as a chronic metabolic stressor: causes, consequences and clinical complications. Exp. Neurol. 233 (2012), 68–78.
159. [159] Rebuffe-Scrive, M., Andersson, B., Olbe, L., Bjorntorp, P., Metabolism of adipose tissue in intraabdominal depots of nonobese men and women. Metab. Clin. Exp. 38 (1989), 453–458.
160. [160] Rebuffe-Scrive, M., Lonnroth, P., Marin, P., Wesslau, C., Bjorntorp, P., Smith, U., Regional adipose tissue metabolism in men and postmenopausal women. Int. J. Obes. 11 (1987), 347–355.
161. [161] Rivest, S., Deshaies, Y., Richard, D., Effects of corticotropin-releasing factor on energy balance in rats are sex dependent. Am. J. Physiol. 257 (1989), R1417–R1422.
162. [162] Rosmond, R., Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology 30 (2005), 1–10.
163. [163] Rosmond, R., Holm, G., Bjorntorp, P., Food-induced cortisol secretion in relation to anthropometric, metabolic and haemodynamic variables in men. Int. J. Obes. Relat. Metab. Disord. 24 (2000), 416–422.
164. [164] Royalty, J.E., Konradsen, G., Eskerod, O., Wulff, B.S., Hansen, B.S., Investigation of safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of a long-acting alpha-MSH analog in healthy overweight and obese subjects. J. Clin. Pharmacol. 54 (2014), 394–404.
165. [165] Ryan, K.K., Mul, J.D., Clemmensen, C., Egan, A.E., Begg, D.P., Halcomb, K., Seeley, R.J., Herman, J.P., Ulrich-Lai, Y.M., Loss of melanocortin-4 receptor function attenuates HPA responses to psychological stress. Psychoneuroendocrinology 42 (2014), 98–105.
166. [166] Saito, Y.A., Schoenfeld, P., Locke, G.R. 3rd, The epidemiology of irritable bowel syndrome in North America: a systematic review. J. Gastroenterol. 97 (2002), 1910–1915.
167. [167] Sajdyk, T.J., Johnson, P.L., Leitermann, R.J., Fitz, S.D., Dietrich, A., Morin, M., Gehlert, D.R., Urban, J.H., Shekhar, A., Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia. J. Neurosci. 28 (2008), 893–903.
168. [168] Sandeep, T.C., Walker, B.R., Pathophysiology of modulation of local glucocorticoid levels by 11beta-hydroxysteroid dehydrogenases. Trends Endocrinol. Metab. 12 (2001), 446–453.
169. [169] Saper, C.B., Chou, T.C., Elmquist, J.K., The need to feed: homeostatic and hedonic control of eating. Neuron 36 (2002), 199–211.
170. [170] Schimmer, B., Funder, J., ACTH, adrenal steroids, and pharmacology of the adrenal cortex. Brunton, L., et al. (eds.) Goodman & Gillman's The Pharmacological Basis of Therapeutics, 2011, McGraw-Hill, New York, NY.
171. [171] Schmidt, M.I., Duncan, B.B., Sharrett, A.R., Lindberg, G., Savage, P.J., Offenbacher, S., Azambuja, M.I., Tracy, R.P., Heiss, G., Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis risk in communities study): a cohort study. Lancet 353 (1999), 1649–1652.
172. [172] Schwartz, M.W., Seeley, R.J., Seminars in medicine of the Beth Israel deaconess medical center. Neuroendocrine responses to starvation and weight loss. New J. Med. 336 (1997), 1802–1811.
173. [173] Schwartz, M.W., Woods, S.C., Porte, D. Jr., Seeley, R.J., Baskin, D.G., Central nervous system control of food intake. Nature 404 (2000), 661–671.
174. [174] Seimon, R.V., Hostland, N., Silveira, S.L., Gibson, A.A., Sainsbury, A., Effects of energy restriction on activity of the hypothalamo-pituitary-adrenal axis in obese humans and rodents: implications for diet-induced changes in body composition. Horm. Mol. Biol. Clin. Invest. 15 (2013), 71–80.
175. [175] Serova, L.I., Laukova, M., Alaluf, L.G., Sabban, E.L., Intranasal infusion of melanocortin receptor four (MC4R) antagonist to rats ameliorates development of depression and anxiety related symptoms induced by single prolonged stress. Behav. Brain Res. 250 (2013), 139–147.
176. [176] Sharma, S., Fernandes, M.F., Fulton, S., Adaptations in brain reward circuitry underlie palatable food cravings and anxiety induced by high-fat diet withdrawal. Int. J. Obes. 37 (2013), 1183–1191.
177. [177] Soderholm, J.D., Yates, D.A., Gareau, M.G., Yang, P.C., MacQueen, G., Perdue, M.H., Neonatal maternal separation predisposes adult rats to colonic barrier dysfunction in response to mild stress. Am. J. Physiol. Gastrointest. Liver Physiol. 283 (2002), G1257–G1263.
178. [178] Stanley, B.G., Lanthier, D., Chin, A.S., Leibowitz, S.F., Suppression of neuropeptide Y-elicited eating by adrenalectomy or hypophysectomy: reversal with corticosterone. Brain Res. 501 (1989), 32–36.
179. [179] Stengel, A., Tache, Y., CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress. Front. Neurosci.-Switz, 8, 2014.
180. [180] Stenzel-Poore, M.P., Duncan, J.E., Rittenberg, M.B., Bakke, A.C., Heinrichs, S.C., CRH overproduction in transgenic mice: behavioral and immune system modulation. Ann. N. Y. Acad. Sci. 780 (1996), 36–48.
181. [181] Steppan, C.M., Bailey, S.T., Bhat, S., Brown, E.J., Banerjee, R.R., Wright, C.M., Patel, H.R., Ahima, R.S., Lazar, M.A., The hormone resistin links obesity to diabetes. Nature 409 (2001), 307–312.
182. [182] Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X.N., Kubo, C., Koga, Y., Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice. J. Physiol. 558 (2004), 263–275.
183. [183] Swinburn, B.A., Sacks, G., Hall, K.D., McPherson, K., Finegood, D.T., Moodie, M.L., Gortmaker, S.L., The global obesity pandemic: shaped by global drivers and local environments. Lancet 378 (2011), 804–814.
184. [184] Szabo, S., Tache, Y., Somogyi, A., The legacy of Hans Selye and the origins of stress research: a retrospective 75 years after his landmark brief “letter” to the editor# of nature. Stress 15 (2012), 472–478.
185. [185] Tache, Y., Million, M., Role of corticotropin-releasing factor signaling in stress-related alterations of colonic motility and hyperalgesia. J. Neurogastroenterol. Motil. 21 (2015), 8–24.
186. [186] Tache, Y., Perdue, M.H., Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function. Neurogastroenterol. Motil. 16:Suppl 1 (2004), 137–142.
187. [187] Tamashiro, K.L., Terrillion, C.E., Hyun, J., Koenig, J.I., Moran, T.H., Prenatal stress or high-fat diet increases susceptibility to diet-induced obesity in rat offspring. Diabetes 58 (2009), 1116–1125.
188. [188] Tartaglia, L.A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., Richards, G.J., Campfield, L.A., Clark, F.T., Deeds, J., Muir, C., Sanker, S., Moriarty, A., Moore, K.J., Smutko, J.S., Mays, G.G., Wool, E.A., Monroe, C.A., Tepper, R.I., Identification and expression cloning of a leptin receptor, OB-R. Cell 83 (1995), 1263–1271.
189. [189] Thompson, M.E., Muller, M.N., Kahlenberg, S.M., Wrangham, R.W., Dynamics of social and energetic stress in wild female chimpanzees. Horm. Behav. 58 (2010), 440–449.
190. [190] Tilg, H., Kaser, A., Gut microbiome, obesity, and metabolic dysfunction. J. Clin. Invest. 121 (2011), 2126–2132.
191. [191] Tilg, H., Moschen, A.R., Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6 (2006), 772–783.
192. [192] Tomlinson, J.W., Moore, J., Cooper, M.S., Bujalska, I., Shahmanesh, M., Burt, C., Strain, A., Hewison, M., Stewart, P.M., Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology 142 (2001), 1982–1989.
193. [193] Tryon, M.S., Stanhope, K.L., Epel, E.S., Mason, A.E., Brown, R., Medici, V., Havel, P.J., Laugero, K.D., Excessive sugar consumption may be a difficult habit to break: a view from the brain and body. J. Clin. Endocrinol. Metab., 2015 (jc20144353).
194. [194] Turnbaugh, P.J., Backhed, F., Fulton, L., Gordon, J.I., Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3 (2008), 213–223.
195. [195] Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., Sogin, M.L., Jones, W.J., Roe, B.A., Affourtit, J.P., Egholm, M., Henrissat, B., Heath, A.C., Knight, R., Gordon, J.I., A core gut microbiome in obese and lean twins. Nature 457 (2009), 480–484.
196. [196] Ulrich-Lai, Y.M., Herman, J.P., Neural regulation of endocrine and autonomic stress responses. Nat. Rev. Neurosci. 10 (2009), 397–409.
197. [197] Ustun, T.B., Ayuso-Mateos, J.L., Chatterji, S., Mathers, C., Murray, C.J., Global burden of depressive disorders in the year 2000. Br. J. Psychiatry 184 (2004), 386–392.
198. [198] Vaneckova, I., Maletinska, L., Behuliak, M., Nagelova, V., Zicha, J., Kunes, J., Obesity-related hypertension: possible pathophysiological mechanisms. J. Endocrinol. 223 (2014), R63–R78.
199. [199] Vicennati, V., Ceroni, L., Gagliardi, L., Gambineri, A., Pasquali, R., Comment: response of the hypothalamic–pituitary–adrenocortical axis to high-protein/fat and high-carbohydrate meals in women with different obesity phenotypes. J. Clin. Endocrinol. Metab. 87 (2002), 3984–3988.
200. [200] Vrieze, A., Van Nood, E., Holleman, F., Salojarvi, J., Kootte, R.S., Bartelsman, J.F., Dallinga-Thie, G.M., Ackermans, M.T., Serlie, M.J., Oozeer, R., Derrien, M., Druesne, A., Van Hylckama Vlieg, J.E., Bloks, V.W., Groen, A.K., Heilig, H.G., Zoetendal, E.G., Stroes, E.S., de Vos, W.M., Hoekstra, J.B., Nieuwdorp, M., Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology, 143(913–916), 2012, e917.
201. [201] Wahlestedt, C., Skagerberg, G., Ekman, R., Heilig, M., Sundler, F., Hakanson, R., Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary–adrenocortical axis in the rat. Brain Res. 417 (1987), 33–38.
202. [202] Wamil, M., Seckl, J.R., Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target. Drug Discov. Today 12 (2007), 504–520.
203. [203] Wang, J., Vanegas, S.M., Du, X., Noble, T., Zingg, J.M., Meydani, M., Meydani, S.N., Wu, D., Caloric restriction favorably impacts metabolic and immune/inflammatory profiles in obese mice but curcumin/piperine consumption adds no further benefit. Nutr. Metab., 10, 2013, 29.
204. [204] Wei, J., Pimple, P., Shah, A.J., Rooks, C., Bremner, J.D., Nye, J.A., Ibeanu, I., Murrah, N., Shallenberger, L., Raggi, P., Vaccarino, V., Depressive symptoms are associated with mental stress-induced myocardial ischemia after acute myocardial infarction. PLoS One, 9, 2014, e102986.
205. [205] Weiss, T., Skelton, K., Phifer, J., Jovanovic, T., Gillespie, C.F., Smith, A., Umpierrez, G., Bradley, B., Ressler, K.J., Posttraumatic stress disorder is a risk factor for metabolic syndrome in an impoverished urban population. Gen. Hosp. Psychiatry 33 (2011), 135–142.
206. [206] Westerbacka, J., Corner, A., Tiikkainen, M., Tamminen, M., Vehkavaara, S., Hakkinen, A.M., Fredriksson, J., Yki-Jarvinen, H., Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 47 (2004), 1360–1369.
207. [207] Whitacre, C.C., Sex differences in autoimmune disease. Nat. Immunol. 2 (2001), 777–780.
208. [208] Williams, G., Bing, C., Cai, X.J., Harrold, J.A., King, P.J., Liu, X.H., The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol. Behav. 74 (2001), 683–701.
209. [209] Williams, G., Harrold, J.A., Cutler, D.J., The hypothalamus and the regulation of energy homeostasis: lifting the lid on a black box. Proc. Nutr. Soc. 59 (2000), 385–396.
210. [210] Woodworth A, Lakhani V, Aleryani SL, Laposata M (2014) The Endocrine System. In: Laboratory Medicine: The Diagnosis of Disease in the Clinical Laboratory (Laposata, M., ed): McGraw-Hill.
211. [211] Xu, X., De Pergola, G., Bjorntorp, P., The effects of androgens on the regulation of lipolysis in adipose precursor cells. Endocrinology 126 (1990), 1229–1234.
212. [212] Yuan, P.Q., Wu, S.V., Wang, L., Tache, Y., Corticotropin releasing factor in the rat colon: expression, localization and upregulation by endotoxin. Peptides 31 (2010), 322–331.
213. [213] Zemel, M.B., Shi, H., Pro-opiomelanocortin (POMC) deficiency and peripheral melanocortins in obesity. Nutr. Rev. 58 (2000), 177–180.
214. [214] Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., Friedman, J.M., Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994), 425–432.